Josef Smolen

thumb Josef Smolen (born March 24, 1950) is an Austrian rheumatologist and immunologist and professor emeritus at the Medical University of Vienna. Since 2018, he is chairman emeritus of the Department of Internal Medicine 3 and the Division of Rheumatology at the Medical University of Vienna and Vienna General Hospital and was the chairman of the 2nd Medical Department and Center for Diagnosis and Therapy of Rheumatic Diseases at the Lainz Hospital, now the Hietzing Clinic of the Vienna Health Association from 1989 to 2017. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Josef Smolen', query time: 0.03s Refine Results
  1. 1
    Think Rheumatoid Arthritis: Causes, Consequences, and Management

    Think Rheumatoid Arthritis: Causes, Consequences, and Management by Josef Smolen, Costantino Pitzalis, Simon Jones, Frank McKenna

    Published 2016-07-01
    Get full text
    Article
  2. 2
    Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials

    Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials by Josef Smolen, Roy Fleischmann, Daniel Aletaha, Yihan Li, Yijie Zhou, Iain Sainsbury, Ivan Lagunes Galindo

    Published 2019-11-01
    Get full text
    Article
  3. 3
    Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis

    Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis by Daniela Sieghart, Alexander Platzer, Paul Studenic, Farideh Alasti, Maresa Grundhuber, Sascha Swiniarski, Thomas Horn, Helmuth Haslacher, Stephan Blüml, Josef Smolen, Günter Steiner

    Published 2018-04-01
    Get full text
    Article
  4. 4
    A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study.

    A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study. by Lucia Vernerova, Frantisek Spoutil, Miroslav Vlcek, Katarina Krskova, Adela Penesova, Milada Meskova, Andrea Marko, Katarina Raslova, Branislav Vohnout, Jozef Rovensky, Zdenko Killinger, Ivana Jochmanova, Ivica Lazurova, Guenter Steiner, Josef Smolen, Richard Imrich

    Published 2016-01-01
    Get full text
    Article
  5. 5
    Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial

    Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial by Tanja Alexandra Stamm, Klaus Peter Machold, Daniel Aletaha, Farideh Alasti, Peter Lipsky, David Pisetsky, Robert Landewe, Desiree van der Heijde, Alexandre Sepriano, Martin Aringer, Dimitri Boumpas, Gerd Burmester, Maurizio Cutolo, Wolfgang Ebner, Winfried Graninger, Tom Huizinga, Georg Schett, Hendrik Schulze-Koops, Paul-Peter Tak, Emilio Martin-Mola, Ferdinand Breedveld, Josef Smolen

    Published 2018-08-01
    Get full text
    Article

Search Tools: